600664.SS

Harbin Pharmaceutical Group Co., Ltd. [600664.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

600664.SS Stock Summary

Top 10 Correlated ETFs

600664.SS


Top 10 Correlated Stocks

600664.SS


In the News

600664.SS Financial details

Company Rating
Buy
Market Cap
7.59B
Income
598.45M
Revenue
15.31B
Book val./share
2.26
Cash/share
1.32
Dividend
-
Dividend %
-
Employees
10.06K
Optionable
No
Shortable
Yes
Earnings
11 Apr 2024
P/E
14
Forward P/E
11.27
PEG
2.22
P/S
0.54
P/B
1.81
P/C
2.22
P/FCF
8.37
Quick Ratio
1.01
Current Ratio
1.25
Debt / Equity
0.44
LT Debt / Equity
0.01
-
-
EPS (TTM)
0.24
EPS next Y
0.26
EPS next Q
-
EPS this Y
26.67%
EPS next Y
6.3%
EPS next 5Y
6.3%
EPS last 5Y
6.3%
Revenue last 5Y
5.01%
Revenue Q/Q
0.49%
EPS Q/Q
96.33%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
4%
ROE
13%
ROC
0.15%
Gross Margin
26%
Oper. Margin
6%
Profit Margin
4%
Payout
8%
Shs Outstand
2.52B
Shs Float
1.2B
-
-
-
-
Target Price
-
52W Range
2.41-3.9
52W High
-2.33%
52W Low
+46.5%
RSI
47
Rel Volume
0.72
Avg Volume
33.74M
Volume
24.39M
Perf Week
-3.62%
Perf Month
11.83%
Perf Quarter
-
Perf Half Y
-13.82%
-
-
-
-
Beta
0.157
-
-
Volatility
0.06%, 0.07%
Prev Close
0.69%
Price
2.93
Change
0%

600664.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
4.374.244.35.175.49
Net income per share
0.140.04-0.420.150.18
Operating cash flow per share
0.28-0.1-0.29-0.070.25
Free cash flow per share
0.23-0.12-0.34-0.10.21
Cash per share
0.790.210.330.620.95
Book value per share
2.371.961.391.561.72
Tangible book value per share
2.321.941.381.561.76
Share holders equity per share
2.371.961.391.561.72
Interest debt per share
0.110.260.730.980.89
Market cap
9.17B10.58B8B8.78B7.58B
Enterprise value
7.38B10.57B8.87B9.5B7.3B
P/E ratio
26.586.79-7.6523.6716.31
Price to sales ratio
0.850.890.740.690.55
POCF ratio
13.24-37.12-10.98-54.0712.18
PFCF ratio
15.85-32.65-9.45-36.7314.23
P/B Ratio
1.561.942.32.281.75
PTB ratio
1.561.942.32.281.75
EV to sales
0.680.890.820.740.53
Enterprise value over EBITDA
6.1510.57-301.6410.587.06
EV to operating cash flow
10.65-37.11-12.18-58.511.73
EV to free cash flow
12.75-32.64-10.48-39.7413.71
Earnings yield
0.040.01-0.130.040.06
Free cash flow yield
0.06-0.03-0.11-0.030.07
Debt to equity
0.040.120.510.60.5
Debt to assets
0.020.050.150.180.16
Net debt to EBITDA
-1.50-29.810.8-0.27
Current ratio
1.411.21.071.111.19
Interest coverage
22.7113.62-9.916.118.13
Income quality
1.72-2.340.7-0.41.22
Dividend Yield
0.15000.010.01
Payout ratio
3.90.08-0.010.170.12
Sales general and administrative to revenue
0.030.030.020.010.01
Research and developement to revenue
0.010.010.010.010.01
Intangibles to total assets
0.050.040.040.040.04
Capex to operating cash flow
-0.160.140.160.47-0.14
Capex to revenue
-0.010-0.01-0.01-0.01
Capex to depreciation
-0.27-0.1-0.32-0.25-0.29
Stock based compensation to revenue
000.0200
Graham number
2.731.393.612.292.67
ROIC
0.060.04-0.120.070.08
Return on tangible assets
0.030.01-0.090.030.04
Graham Net
-0.1-0.55-0.95-0.85-0.5
Working capital
2.11B1.24B501.08M878.23M1.56B
Tangible asset value
5.73B5.42B3.46B3.85B4.42B
Net current asset value
1.58B747.36M-51.09M311.05M1.07B
Invested capital
0.040.120.510.60.5
Average receivables
3.61B4B4.76B4.98B5.13B
Average payables
3.25B3.43B3.7B3.58B3.5B
Average inventory
1.71B1.86B1.94B1.96B1.93B
Days sales outstanding
115.95140.72167.98142.6138.97
Days payables outstanding
145.3151.07158.6130.15123.15
Days of inventory on hand
78.1782.2280.577.1363.3
Receivables turnover
3.152.592.172.562.63
Payables turnover
2.512.422.32.82.96
Inventory turnover
4.674.444.534.735.77
ROE
0.060.02-0.30.10.11
Capex per share
-0.05-0.01-0.05-0.03-0.04

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.421.521.611.541.86
Net income per share
0.020.120.050.020.05
Operating cash flow per share
0.020.120.050.140.13
Free cash flow per share
0.020.110.040.140.13
Cash per share
0.710.950.971.031.32
Book value per share
1.61.721.821.852.26
Tangible book value per share
1.621.761.871.92.33
Share holders equity per share
1.61.721.821.852.26
Interest debt per share
0.880.870.860.820.99
Market cap
6.63B7.58B7.61B8.05B7.09B
Enterprise value
7.02B7.3B7.26B7.45B6.34B
P/E ratio
32.376.1515.5533.316.44
Price to sales ratio
1.851.981.932.131.87
POCF ratio
129.4624.662.223.0725.86
PFCF ratio
170.8426.871.723.727.33
P/B Ratio
1.651.751.711.781.53
PTB ratio
1.651.751.711.781.53
EV to sales
1.961.911.851.981.67
Enterprise value over EBITDA
51.726.4434.3650.2433.42
EV to operating cash flow
137.1623.759.3821.3723.12
EV to free cash flow
18125.8268.4421.9624.44
Earnings yield
0.010.040.020.010.02
Free cash flow yield
0.010.040.010.040.04
Debt to equity
0.550.50.470.440.44
Debt to assets
0.170.160.150.150.14
Net debt to EBITDA
2.9-1-1.63-3.99-3.96
Current ratio
1.161.191.221.231.25
Interest coverage
9.7215.8911.969.5812.27
Income quality
1115.772.54
Dividend Yield
00000
Payout ratio
0.280.050.10.170.09
Sales general and administrative to revenue
0.14-0.110.05-0.030.14
Research and developement to revenue
0.010.010.0100.01
Intangibles to total assets
0.040.040.040.040.04
Capex to operating cash flow
-0.24-0.08-0.13-0.03-0.05
Capex to revenue
0-0.01000
Capex to depreciation
-0.17-0.35-0.21-0.120.1
Stock based compensation to revenue
00000
Graham number
0.862.181.431.011.64
ROIC
0.010.050.020.010.02
Return on tangible assets
00.020.0100.01
Graham Net
-0.66-0.5-0.44-0.43-0.42
Working capital
1.22B1.56B1.75B1.86B2.03B
Tangible asset value
4.08B4.42B4.57B4.64B4.77B
Net current asset value
674.71M1.07B1.26B1.38B1.58B
Invested capital
0.550.50.470.440.44
Average receivables
5.28B5.36B5.37B5.46B5.49B
Average payables
3.61B3.63B3.6B3.84B3.9B
Average inventory
1.71B1.77B1.77B1.79B1.83B
Days sales outstanding
137.31123.93125.64129.46131.68
Days payables outstanding
120.67117.2112.79125.77122.84
Days of inventory on hand
55.7660.2453.158.3358.23
Receivables turnover
0.660.730.720.70.68
Payables turnover
0.750.770.80.720.73
Inventory turnover
1.611.491.691.541.55
ROE
0.010.070.030.010.02
Capex per share
0-0.01-0.010-0.01

600664.SS Frequently Asked Questions

What is Harbin Pharmaceutical Group Co., Ltd. stock symbol ?

Harbin Pharmaceutical Group Co., Ltd. is a CN stock and trading under the symbol 600664.SS

What is Harbin Pharmaceutical Group Co., Ltd. stock quote today ?

Harbin Pharmaceutical Group Co., Ltd. stock price is $2.93 today.

Is Harbin Pharmaceutical Group Co., Ltd. stock public?

Yes, Harbin Pharmaceutical Group Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap